CPT1A and ovarian cancer: CPT1A upregulation has been found to promote the proliferation, survival, and invasion of several cancer types, including colorectal cancer (190–192), nasopharyngeal cancer (193), ovarian cancer (194, 195), glioblastoma (196), gastric cancer (197), and HCC (198), and in many cases is associated with poor prognosis and metastasis.